The Program to Assess the Influence of Routing and In-depth Consultation of Patients With Cardiovascular Risk Factors on the Choice of Medicine and Treatment Compliance
The Program to Assess the Influence of Routing and In-depth Consultation of Patients With Cardiovascular Risk Factors on the Choice of Medicine and Treatment Compliance
A systematic collection of retrospective and prospective data based on non-interventional patient observation, aimed to assess the risks, course and outcomes of a disease or a group of diseases:
The research program will have two parts:
Stage 1: identification of patients with moderate, high and very high cardiovascular risk, not having diseases of atherosclerotic genesis and requiring lipid-lowering drugs.
Stage 2: a prospective observation of patients receiving primary medical prophylaxis of CVD with atorvastatin.
Inclusion criteria:
Data on the following subjects is planned to be collected in the project:
Exclusion criteria:
No contraindications to statin treatment and not taking stating at study entry.
History of the following clinically significant events and conditions:
(а) myocardial infarction (б) stroke (в) transient ischemic attack
Presence of the following diseases at the time of a statin administration:
(а) ischemic heart disease (б) heart failure (в) peripheral artery atherosclerosis (г) atherosclerotic stenosis of brachiocephalic arteries with cerebrovascular disease .
Subjects must give their consent for processing of their personal data for the purposes of this scientific project.